Antiglaucoma compositions and methods

Details Antiglaucoma compositions and methods Antiglaucoma compositions and methods

1994-04-07

1997-11-18

Fay, Zohreh

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 2, 514 3, 514 4, 514 5, 514 6, 514 7, 514 8, 514 9, 514 10, 514 11, 514 12, 514 13, 514 14, 514 15, 5142362, 514913, A61K 3714, A61K 3716, A61K 3816, A61K 3808

Patent

active

056887701

ABSTRACT:
The present invention relates to ophthalmo-logical pharmaceutical compositions comprising a renin inhibitor and to methods for using said composition in the treatment of glaucoma.

REFERENCES:
patent: 3985875 (1976-10-01), Hayaski, et al.
patent: 4185096 (1980-01-01), Castro et al.
patent: 4269827 (1981-05-01), Burton et al.
patent: 4384994 (1983-05-01), Veber et al.
patent: 4424207 (1984-01-01), Szelke et al.
patent: 4455303 (1984-06-01), Burton
patent: 4470971 (1984-09-01), Boger et al.
patent: 4477440 (1984-10-01), Boger et al.
patent: 4477441 (1984-10-01), Boger et al.
patent: 4478826 (1984-10-01), Veber et al.
patent: 4478827 (1984-10-01), Haber et al.
patent: 4479941 (1984-10-01), Veber et al.
patent: 4481192 (1984-11-01), Cazaubon et al.
patent: 4485099 (1984-11-01), Boger et al.
patent: 4510085 (1985-04-01), Hansen, Jr., et al.
patent: 4514332 (1985-04-01), Hansen, Jr., et al.
patent: 4574127 (1986-03-01), Baldwin et al.
patent: 4602093 (1986-07-01), Baldwin et al.
patent: 4749698 (1988-06-01), Neiss et al.
patent: 4906613 (1990-03-01), Watkins
patent: 5036048 (1991-07-01), Watkins
patent: 5352666 (1994-10-01), Watkins
Hypertension 6 (Supp I): I-111, 1984.
Science 175: 656, 1972.
J Pharm Exp. Ther. 203: 485, 1977.
R.R. Luther, et al., Renin Inhibitors: Specific Modulators of the Renin-Angiotensin system, Arzneim-Forsch/Drug Res. 39(1), Nr.1 (1989), pp. 1-5.
Miguel A. Ondetti, et al., Inhibition of the Renin-Angiotensin System. A New Approach to the Therapy of Hypertension, Journal of Medicinal Chemistry vol. 24, No. 4, 4/81, pp. 355-361.
Ionitesu, Oftalmologia vol. 26, No. 2, (1982) pp. 137-138.
Hypertension 4 (Suppl II): II-59, 1982.
Biochem. J. 205: 43, 1982.
Biochem. Biophys, Res. Commun. 97(1): 230, 1980.
Biochem. Biophys. Res. Commun. 118(3): 929, 1984.
Biochemistry 12: 3877, 1973.
Biochemistry 14: 3892, 1975.
Nature 303: 81, 1983.
Nature 299: 555, 1982.
Peptides: Structure and Function, ed V.J Hruby, Rockford, Illinois, Pierce Chemical Co., 1984.
Proc. Natl. Acad. Sci. USA 81: 48, 1984.
Biochem. Biophys. Res. Commun. 100: (1) 177, 1981.
J. Clin. Endocrinol. 27: 699, 1967.
Biochem. Parmacol. 20: 914, 1971.
Proc. Soc. Exp. Biol. Med. 155: 468, 1977.
Am. J. Physiol. 234(6): E 593, 1978.
Biochemistry 19: 2616, 1980.
J. Chem. Soc. Chem. Commun: 109, 1985.
Kokubu, et al., Hypertension: 7(3): 837, (1985).
Luly, et al., Pharmacologist 27(3): 260, 1985.
Biochem. Biophys. Res. Commun. 54: 1356, 1973.

Affiliated with

Also associated with

Rating

Antiglaucoma compositions and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antiglaucoma compositions and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiglaucoma compositions and methods will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1565662